Michelle Ho

Michelle Ho currently serves as an Associate at 5AM Ventures, operating as a venture capital investor dedicated to early-stage opportunities within the global life sciences sector. In her current role at the investment firm, she is primarily responsible for evaluating and supporting emerging biotechnology and healthcare startups that are actively developing targeted therapeutics. Her investment methodology relies on a rigorously analytical approach to sourcing, conducting due diligence, and assessing promising clinical and preclinical opportunities across the broader medical landscape. By leveraging her specialized domain expertise in healthcare therapeutics, she assists portfolio companies in navigating the complex developmental pathways required to bring novel medical treatments to the commercial market. Ultimately, Ho maintains a dedicated professional focus on deploying early-stage venture capital into specialized life sciences enterprises to advance the next generation of clinical healthcare solutions.